Profile data is unavailable for this security.
About the company
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
- Revenue in USD (TTM)2.61bn
- Net income in USD-322.37m
- Incorporated1975
- Employees8.03k
- LocationBio Rad Laboratories Inc1000 ALFRED NOBEL DRHERCULES 94547-1811United StatesUSA
- Phone+1 (510) 724-7000
- Fax+1 (510) 741-5817
- Websitehttps://www.bio-rad.com/
| Holder | Shares | % Held |
|---|---|---|
| CSS LLCas of 31 Mar 2024 | 1.81k | 0.04% |
| Buckingham Strategic Wealth LLCas of 31 Mar 2024 | 760.00 | 0.02% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 692.00 | 0.01% |
| Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 170.00 | 0.00% |
| Whittier Trust Co.as of 31 Mar 2024 | 160.00 | 0.00% |
| Edward D. Jones & Co. LP (Investment Management)as of 31 Mar 2024 | 33.00 | 0.00% |
| Parametric Portfolio Associates LLCas of 31 Mar 2024 | 32.00 | 0.00% |
| JNBA Financial Advisors, Inc.as of 31 Mar 2024 | 2.00 | 0.00% |
